CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies-Reference-Cited by-同舟云学术

CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies

Published:2013-06-26 Issue:5 Volume:127 Page:681-690
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Luo Xinni¹,Hou Le¹,Shi Haishan¹,Zhong Xiaomei¹,Zhang Yufeng¹,Zheng Dong¹,Tan Yan¹,Hu Guoyan²,Mu Nan³,Chan Jianping³,Chen Xinru¹,Fang Yaxiu¹,Wu Fengchun⁴,He Hongbo⁵,Ning Yuping¹

Affiliation:

1. Department of Neurology; Guangzhou Brain Hospital; Affiliated Hospital of Guangzhou Medical College; Guangzhou Guangdong China

2. Medical Laboratory; Guangzhou Brain Hospital; Affiliated Hospital of Guangzhou Medical College; Guangzhou Guangdong China

3. Department of Geriatrics; Guangzhou Brain Hospital; Affiliated Hospital of Guangzhou Medical College; Guangzhou Guangdong China

4. Department of Schizophrenia; Guangzhou Brain Hospital; Affiliated Hospital of Guangzhou Medical College; Guangzhou Guangdong China

5. Neuropsychiatry Research Institute; Guangzhou Brain Hospital; Affiliated Hospital of Guangzhou Medical College; Guangzhou Guangdong China

Funder

Chinese National Science Foundation

Guangdong Science and Technology Program

Guangzhou Science and Technology Program

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.12331/fullpdf

Reference57 articles.

1. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain;Bernstein;J. Neurocytol.,1999

2. The genetics of Alzheimer disease: back to the future;Bertram;Neuron,2010

3. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia;Bibl;Brain,2006

4. Combined Analysis of CSF Tau, Abeta42, Abeta1-42% and Abeta1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia;Bibl;Int. J. Alzheimers. Dis.,2010

5. Neurodegeneration and energy metabolism: from chemistry to clinics;Blandini;Cell Death Differ.,2004

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biofluid biomarkers for Alzheimer’s disease;Frontiers in Aging Neuroscience;2024-04-10

2. Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives;Molecular Psychiatry;2024-01-16

3. Clinical biomarkers for Lewy body diseases;Cell & Bioscience;2023-11-14

4. Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression;Biomedicines;2023-03-10

5. Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease;Alzheimer's Research & Therapy;2022-12-31